R
Richard C. Becker
Researcher at University of Cincinnati Academic Health Center
Publications - 692
Citations - 51153
Richard C. Becker is an academic researcher from University of Cincinnati Academic Health Center. The author has contributed to research in topics: Myocardial infarction & Clopidogrel. The author has an hindex of 92, co-authored 674 publications receiving 45844 citations. Previous affiliations of Richard C. Becker include Duke University & University of Brescia.
Papers
More filters
Journal ArticleDOI
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
Manesh R. Patel,Kenneth W. Mahaffey,Jyotsna Garg,Guohua Pan,Daniel E. Singer,Werner Hacke,Günter Breithardt,Jonathan L. Halperin,Graeme J. Hankey,Jonathan P. Piccini,Richard C. Becker,Christopher C. Nessel,John F. Paolini,Scott D. Berkowitz,Robert M. Califf +14 more
TL;DR: In patients with atrial fibrillation, rivaroxaban was noninferior to warfarin for the prevention of stroke or systemic embolism and there was no significant between-group difference in the risk of major bleeding, although intracranial and fatal bleeding occurred less frequently in the rivroxaban group.
Journal ArticleDOI
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
Lars Wallentin,Richard C. Becker,Andrzej Budaj,Christopher P. Cannon,Håkan Emanuelsson,Claes Held,Jay Horrow,Steen Husted,Stefan James,Hugo A. Katus,Kenneth W. Mahaffey,Benjamin M. Scirica,Allan M. Skene,Philippe Gabriel Steg,Robert F. Storey,Robert A. Harrington +15 more
TL;DR: In patients who have an acute coronary syndrome with or without ST-segment elevation, treatment with ticagrelor as compared with clopidogrel significantly reduced the rate of death from vascular causes, myocardial infarction, or stroke without an increase in the rates of overall major bleeding but with an increase of non-procedure-related bleeding.
Journal ArticleDOI
Consensus and Future Directions on the Definition of High On-Treatment Platelet Reactivity to Adenosine Diphosphate
Laurent Bonello,Udaya S. Tantry,Rossella Marcucci,Ruediger Blindt,Dominick J. Angiolillo,Richard C. Becker,Deepak L. Bhatt,Marco Cattaneo,Jean-Philippe Collet,Thomas Cuisset,Christian Gachet,Gilles Montalescot,Lisa K. Jennings,Dean J. Kereiakes,Dirk Sibbing,Dietmar Trenk,Jochem W. van Werkum,Franck Paganelli,Matthew J. Price,Ron Waksman,Paul A. Gurbel +20 more
TL;DR: A consensus opinion is provided on the definition of high on-treatment platelet reactivity to ADP based on various methods reported in the literature and how this measurement may be used in the future care of patients.
Journal ArticleDOI
Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta-analysis
Sarah G. Chu,Richard C. Becker,Peter B. Berger,Deepak L. Bhatt,John W. Eikelboom,Barbara A. Konkle,Emile R. Mohler,Muredach P. Reilly,Jeffrey S. Berger,Jeffrey S. Berger +9 more
TL;DR: See also Machin SJ, Briggs C. Mean platelet volume: a quick, easy determinant of thrombotic risk?
Journal ArticleDOI
Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation
Abstr Act,James D. Douketis,Alex C. Spyropoulos,Scott Kaatz,Richard C. Becker,Joseph A. Caprini,Andrew Dunn,David A. Garcia,Alan K. Jacobson,Amir K. Jaffer,David F. Kong,Sam Schulman,Thomas L. Ortel +12 more
TL;DR: In patients with atrial fibrillation who had warfarin treatment interrupted for an elective operation or other elective invasive procedure, forgoing bridging anticoagulation was noninferior to perioperative bridging with low-molecular-weight heparin for the prevention of arterial thromboembolism and decreased the risk of major bleeding.